We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of Tongue Lymphangioma with Intralesional Combination Injection of Steroid, Bleomycin and Bevacizumab.
- Authors
Jungil Hwang; Yung Ki Lee; Jin Sik Burm
- Abstract
Lymphangioma is a congenital malformed lymphatic tumor that rarely involves the tongue. In our clinic, a 10-year-old female presented with lymphangioma circumscriptum involving the right two-thirds of the tongue. We administered an intralesional combination injection of triamcinolone, bleomycin, and bevacizumab as a treatment. Almost complete remission after combination therapy was achieved without complications such as edema, swallowing difficulties or recurrence. Bevacizumab, an inhibitor of vascular endothelial growth factor, was effective for the treatment of lymphangioma of the tongue in this case. No recurrence was noted at the 1-year follow up.
- Subjects
LYMPHANGIOMAS; TONGUE cancer; BEVACIZUMAB; THERAPEUTICS; CANCER treatment
- Publication
Archives of Craniofacial Surgery, 2017, Vol 18, Issue 1, p54
- ISSN
2287-1152
- Publication type
Article
- DOI
10.7181/acfs.2017.18.1.54